The 4th International Electronic Conference on Metabolomics
13–15 Oct 2025
Metabolomics, metabolome, analysis of organisms
- Go to the Sessions
-
- S1. Clinical Application of Metabolomics with Special Reference to the Endocrinological Arena
- S2. Technological Advances in Metabolomics
- S3. Advanced Metabolomics and Data Analysis Approaches
- S4. Metabolomics for Precision Nutrition in Humans and Animals
- S5. Applications of Metabolomics in Pharmacology and New Drug Development
- S6. Microbial Metabolites with Novel Functions in Diseases and Health
- Event Details
IECM 2025 is FREE for Participation!
Join us today to register and submit your abstract, and be part of cutting-edge discussions and networking opportunities!
REGISTER
SUBMIT YOUR ABSTRACT
Welcome from the Chairs
Dear Colleagues,
We are delighted to welcome you to the 4th International Electronic Conference on Metabolomics(IECM2025), an event set to bring together leading researchers, innovators, and practitioners in the rapidly evolving field of metabolomics. This returning conference builds on the resounding success of our first 3 conferences in 2016, 2017, and 2018 and promises to provide an exceptional platform for intellectual exchange, collaboration, and exploration of cutting-edge advancements.
Metabolomics offers unparalleled insight into metabolic homeostasis and dysfunction within biological systems since metabolites (the metabolome) often more directly reflects physiological status than genes (the genome) or proteins (the proteome). As an indispensable tool in systems biology, metabolomics enables both comprehensive profiling of the metabolome and precise characterisation of functional metabolites, driving innovation across diverse domains in science and medicine.
Organized and proudly sponsored by Metabolites (ISSN 2218-1989), a peer-reviewed journal dedicated to advancing knowledge in this field, this conference will feature six dynamic sessions exploring diverse aspects of metabolomics:
- Clinical Metabolomics: Unlocking Insights for Endocrinological Disorders
- Pioneering Technological Frontiers in Metabolomics
- Breaking Barriers with Advanced Data Analysis in Metabolomics
- Precision Nutrition Meets Metabolomics: Transforming Human and Animal Health
- Metabolomics in Drug Discovery: Shaping the Future of Pharmacology
- Microbial Metabolites: Novel Pathways to Health and Therapeutics
Accepted abstracts will be published in the Journal Proceedings, and participants presenting unpublished findings will have the opportunity to submit manuscripts for inclusion in a Special Issue of Journal Metabolites, with a significant discount on APC charges after peer review.
On behalf of the dynamic Metabolites editorial board and our dedicated editorial team, we warmly invite you to join us for this exciting event. Whether through presenting your latest research or engaging with the diverse community of metabolomics professionals, your participation will enrich the collective discourse and help shape the future of this vibrant field.
We look forward to welcoming you to this virtual conference and celebrating the incredible advancements in metabolomics together.
Event Chairs
Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN 55108, USA
Professor Chen received his PhD in Pharmaceutical Science from Rutgers University and conducted his postdoctoral research at the National Cancer Institute of NIH. He had extensive research experience in metabolomics, nutritional biochemistry, animal metabolism, toxicology, and xenobiotic metabolism. His research focuses on mechanistic characterization of metabolic changes induced by dietary, chemical and pathophysiological challenges in human and animals.
chichen@umn.edu
School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0SP, UK
As a strategic consultant at the University of Cambridge, Dr Reza Salek lead translational initiatives in Artificial Intelligence and MedTech program development, with a focus on software and AI as a medical device (SaMD and AIaMD) within regulatory compliance frameworks. Previously, he served as Head of Application Development and Vice President for Bruker’s R&D, directing multidisciplinary teams to advance high-performance applications in medical and analytical devices. His career includes designing scalable workflow solutions for multi-omics data analysis at the International Agency for Research on Cancer (IARC/WHO), driving insights into cancer epidemiology. At EMBL-EBI and the University of Cambridge, he established comprehensive knowledge resources and workflow infrastructures to support FAIR data governance and enable sophisticated data integration and interoperability.
rms72@cam.ac.uk
Session chairs
Dr. Yunping Qiu
The Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, Bronx, NY 10461, USA
Prof. Cecília R.C. Calado
Chemical Engineering Department, ISEL- Instituto Superior de Engenharia de Lisboa, Polytechnic University of Lisbon, Lisbon, Portugal
Prof. Hunter N. B. Moseley
Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA
Prof. Dr. Shu-Hai Lin
Xiamen University, Xiamen, China
Dr. Madhu Basetti
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
Prof. Dr. Giuseppe Paglia
School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy
Prof. Dr. Chi Chen
Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN 55108, USA
Co-Chair
Dr. Ala F. Nassar
School of Medicine, Yale University, New Haven, CT, USA
ala.nassar@yale.edu
Sessions
S2. Technological Advances in Metabolomics
S3. Advanced Metabolomics and Data Analysis Approaches
S4. Metabolomics for Precision Nutrition in Humans and Animals
S5. Applications of Metabolomics in Pharmacology and New Drug Development
S6. Microbial Metabolites with Novel Functions in Diseases and Health
Publication Opportunities
1. Metabolites Journal Publication
Participants in this conference are cordially invited to contribute a full manuscript to the Conference's Special Issue, published in Metabolites ( ISSN: 2218-1989 , Impact Factor 3.4), with a 20% discount on the publication fee. Please note, if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
2. Proceeding Paper Publication
All accepted abstracts will be published in the conference report of The 4th International Electronic Conference on Metabolomics ( ISSN: 2218-1989) in the Biology and Life Science; if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference.
Authors are asked to disclose that it is a proceeding paper of the IECM2025 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings submission deadline: 1 December 2025
Manuscripts for the proceedings issue must be formatted as follows:
Title.
Full author names.
Affiliations (including full postal address) and authors' e-mail addresses.
Abstract.
Keywords.
Introduction.
Methods.
Results and Discussion.
Conclusions.
Acknowledgements.
References.
Registration
The registration for IECM 2025 will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 09 October 2025.
Instructions for Authors
IECM 2025 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
Important Deadline
1. Deadline for abstract submission: 31st July 2025
2. Announcement of oral and poster abstract results: 11th September 2025. You will be notified of the acceptance of an oral/poster presentation in a separate email.
Abstract submissions should be completed online by registering with www.sciforum.net and using the "Submit Abstract" function once logged into the system. No physical template is necessary.
1. The abstract structure should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
4. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
Detailed Requirements:
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Note: We only accept live presentations.
- Should include the title, authors, contact details and main research findings, as well as tables, figures and graphs where necessary.
- Size in pixel: 1080 width x 1536 height–portrait orientation.
- Size in cm: 38,1 width x 54,2 height–portrait orientation.
- Font size: ≥16.
- Examples of successful submissions can be viewed here at the following links: (1), (2), (3)
- You can use our free template to create your poster. The poster template can be downloaded HERE.
We will reach out to you closer to the dates of the conference with more information.
It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 6 awards including Best Oral Presentation Awards and Best Poster Awards.
The Awards
Number of Awards Available: 6
The Best Oral Presentation Awards are given to the paper judged to make the most significant oral contribution to the conference.
The Best Poster Awards are given to the submission judged to make the most significant and interesting poster for the conference.
There will be six winners selected for these awards.
Conference Secretariat
Ms. Miruna Nicolcioiu
Mr. Zack Yang
Email: iocmb2025@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
S1. Clinical Application of Metabolomics with Special Reference to the Endocrinological Arena
Session Chairs
Dr. Yunping Qiu, The Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, Bronx, NY 10461, USA
Prof. Dr. Giuseppe Paglia, School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy
S5. Applications of Metabolomics in Pharmacology and New Drug Development
Session Chairs
Prof. Dr. Cecília R.C. Calado, Chemical Engineering Department, ISEL- Instituto Superior de Engenharia de Lisboa, Polytechnic University of Lisbon, Lisbon, Portugal
Dr. Ala F. Nassar, School of Medicine, Yale University, New Haven, CT, USA